Communications and Publications Division (CPD) of the IFCC
Editor: Tahir Pillay, MB ChB, PhD, FRCPath (Lon), FCPath (SA)
Department of Chemical Pathology, University of Pretoria, South Africa
E-mail: enews@ifcc.org

International Federation of Clinical Chemistry and Laboratory Medicine

N° 10 – November 2018

In t h is issue
 The evolving digital era and ethics

3

 IFCC and Global Healthcare Organizations join ABBOTT
to launch the UNIVANTS of Healthcare Excellence Award

4

 AACC Learning Lab for Laboratory Medicine on NEJM Knowledge+

6

 VLP Report: Philippine Council for Quality Assurancein Clinical Laboratories (PCQACL)

9

 NEWS FROM REGIONAL FEDERATIONS AND MEMBER SOCIETIES News from the Vietnamese Associationof Clinical Biochemists (VACB)

11

 News from the Japanese Society of Clinical Chemistry (JSCC)

12 IFCC's Calendar of Congresses, Conferences & Events

14

The evolving digital era and ethics
by Bernard Gouget
Chair, IFCC Committee on Mobile Health and Bioengineeringin Laboratory Medicine (C-MHBLM)
SFBC-International Committee
General Secretary of the International Francophone Federationof Clinical Biology and Laboratory Medicine (FIFBCML)
Counselor for Public Health-FHF
Chair-Human Health Care Committee-COFRAC
Any health system today is confronted with new societal and ethicalchallenges and the growing pace of scientific development. The great increase in chronic diseases as well as technical progress, the emergence of
new therapies and the acceleration of the digital revolution will change
healthcare needs and approaches to care.

Dr. Bernard Gouget

Digital technology is fundamentally positioned at the heart of all healthcare systems. Its development is part of an extremely active international context. It is a major and irreversible element for the organizationof care and a source of progress for improving quality and efficiency inhealth. The expected benefits in the field of teaching and research arealso considerable. All professionals and citizens are directly concernedwith this movement of technological innovation and the democratization of digital technology in health.

The French National Ethics Advisory Council reported in a recent opinion piece that digital technology also concerns data collection, the development of learning algorithms (AI), and their applications, as well as in-silico
modeling of diseases and modeling the action of new drug molecules. Today, the human part in medical practice
is constantly being reduced by robotization in the medical technology sectors. The future becomes the present
with algorithms already validated by peers. Their developments in medical decision making assistance or prescription assistance software allow diagnoses and therapeutic approaches to be facilitated and refined thanks
to computing potential multiplied via big data or international registers collating the data of rare patients. Digital innovations in health have become essential and the quality of care is improved to the benefit of patients
through more personalized and predictive management and care is more secure, with better traceability. The
gains that can be obtained also concern prevention and screening, care, support and healthcare governancemore generally.
The use of digital technology can constitute a source of concern for professionals and users, especially regarding the use of data and associated services. It is therefore essential that the shift to digital technology is donein the context of ethical values and standards in order to structure and set limits for use. Respecting the rights
and freedoms of individuals and protecting health data and the extent they are shared to improve clinical andbiological quality are imperative. Algorithmic medicine must not deprive patients of their ability to participate
in the process of constructing the management of their disease. It is also necessary to be vigilant that the digital revolution does not create new inequalities and does not penalize non-digital citizens, who are fragile populations with significant health needs. The objective of e-health is to reduce the risks of disease, obtain better
treatment and care with a patient who is no longer an object of care, but rather an actor in their healthcare.
Article continued on next page3

In this context, ethical reflection on data, algorithms,
practices and AI must be undertaken very early inthe conception and development of solutions. For
this purpose, research into digital ethics should be
increased.
The digital transformation is a source of motivation; it
is urgent to take action to anticipate changes in jobs
and possibilities for new functions and professions inhealth. The appeal of our profession also depends on
training in the necessary skills to respond to the challenges of digital health. Preparing for the future means
training future professionals and preparing them tounderstand the ever-faster progress in medical knowhow. Laboratory medicine is diversifying. Professionals
are in demand to work more collectively in a comprehensive approach to care and share the same engagement and professional culture. Dialogue, responsiveness, collective deliberation, and cross-referencing are

all useful to further improve the quality of care in an
ethical framework and get the most out of the added value of laboratory medicine. Bioethics and digitaltechnology are increasingly the subject of practicaland theoretical training. Ethical considerations at theinternational level are inseparable from the dissemination of tools. The organizational and cultural heterogeneity of the various national ethics committees
with different regulatory or legislative responses leads
to the creation of coordinated digital committees tobetter communicate and understand our cultural differences.
The digital revolution penetrates all healthcare sectors
and requires unprecedented ethical reflections driven
by scientific advances. Our Federation can doubtlessly
be a place for transcultural sharing and reflection to
study and debate new ethical problems in laboratory
medicine.

IFCC and Global Healthcare Organizations join ABBOTT
to launch the UNIVANTS of Healthcare Excellence Award
Global recognition for cross-functional care teams achieving measurably better healthcare

Apply Now!
IFCC, together with leading global healthcare organizations, AACC, EHMA, Modern Healthcare, and HIMSS,in partnership with Abbott, is part of the UNIVANTS of
Healthcare Excellence Award initiative.
UNIVANTS, which stands for “unity” and “avant-garde” is a unique healthcare industry award that honours integrated multidisciplinary clinical care teams
with innovative approaches to achieve measurably
better healthcare performance for patients, clinicians,payers and healthcare institutions.
“Through the UNIVANTS of Healthcare ExcellenceAward program we hope to encourage healthcare
system departments to break out of their silos andpersuade all areas of the hospital to take advantageof the data from the lab to solve critical needs in thehospital and, above all, improve patient outcomes,”
said Howard Morris, PhD, President of the IFCC.
“Our partners currently include global organizations
dedicated to lab medicine, healthcare management

and healthcare media,” said Lisa Rose, divisional vicepresident, global marketing, Abbott. “Just as there is aneed for healthcare providers to reach across the aisle
and break down silos, our multi-disciplinary partners
also are unifying to find solutions to the evolving stateof healthcare together.”
The call to action for 2019 nominations for this prestigious award occurred at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago and featured healthcare teams that have already achieved
success.
By recognizing the integrated clinical care teams who
are already achieving measurably better healthcare
and leveraging expertise across disciplines, the award
is intended to inspire healthcare professionals aroundthe world.
The award partner organizations will be sharing bestpractices in publications, in roundtable events, andmore.
Article continued on next page4

The founding partners invite teams to apply for the inaugural award who demonstrate:ÂÂ Strength in Unity – teams working across disciplines to break down silos and develop care projects ascollective and integrative teams
ÂÂ Avant Garde – implementation of ideas that are at the forefront of change and mobilizing insights fromthe clinical laboratory to transform healthcare delivery
ÂÂ Nurturing and Passion - cultivation of communities, passionate about integrated clinical care and enabling others to do the same
The awards are open to all healthcare professionals and teams regardless of affiliation with Abbott. All partners,
excluding Abbott, will evaluate submissions to determine the 2019 winners. Award entries are being accepted
through March 2019.
For more information and to enter the 2019 UNIVANTS of Healthcare Excellence Awards, please visit:
UnivantsHCE.com
Award-winning teams for the UNIVANTS of Healthcare Excellence Award will be recognized for their contributions in multiple ways, locally and globally.
For applications, register at:
https://www.diagnostics.abbott/int/en/knowledge-center/healthcare-excellence-program/verification

FOR SOMETHING GREATER
Announcing the 1st Annual UNIVANTS of Healthcare
Excellence Award, celebrating teams of UNIFIERS who
have applied AVANT-GARDE approaches to achievemeasurably better healthcare outcomes.
Learn more and apply for the UNIVANTS of Healthcare
Excellence Award at UnivantsHCE.com.
IN PARTNERSHIP WITH

© 2018 Abbott Laboratories

5

AACC Learning Lab for Laboratory Medicine on NEJM Knowledge+
A cloud-based adaptive learning programby Nader Rifai
Founder of CCTC programmeby Christina Ellervik
Co-editor, AACC Learning Lab

In the past several months, we reported on the Clinical
Chemistry Trainee Council (www.traineecouncil.org)
and its various educational features. Here, we wish
to describe another Clinical Chemistry initiative, the
AACC Learning Lab for Laboratory Medicine on NEJM
Knowledge+ (http://www.aacc.org/education-and-career/learning-lab), known as the Learning Lab (Figure 1).
This ambitious programme is a collaborative effort between NEJM Group, the publisher of the New England
Figure 1

AACC - Learning Lab

Journal of Medicine, AACC, the publisher of Clinical
Chemistry, and Area9 Lyceum, a global leader in education technology.
The Learning Lab is a cloud-based educational programme, which utilizes the concept of adaptive learning, the closest method to personalized education.
Through sophisticated computer algorithms, timing of
the learner’s response, and assessing the learner’s confidence in the answers provided, the system identifies
the areas in which the learner is deficient and provides
the appropriate learning materials to correct the deficiency. Learning Lab can be accessed via mobile devices
and enables efficient learning in small blocks of time.
When completed, this curriculum-based program willconsist of over 120 courses in the six main disciplines
of laboratory medicine including clinical chemistry, laboratory genomics, haematology/coagulation, transfusion medicine, microbiology, and clinical immunology(Figure 2); at present, over 40 courses are available.
Over 90 clinical laboratory scientists and physiciansfrom the United States, United Kingdom, Canada, Australia, Iceland, Denmark, Norway, Croatia, Singapore
and South Africa have volunteered to build courses for
the Learning Lab. A typical course consists of 100-150
granular learning objectives; every learning objective iscoupled with two probes and a learning resource. The
probes are the actual questions and can be presented in one of nine different formats including multiple
choice, fill-in-the-blank, matching and categorizing,
and clinical cases. Morphology images, tables, chromatograms, and figures can be used in the probes and thelearning resources to enhance the learning experience.
Article continued on next page6

Figure 2

AACC Learning Lab for Laboratory Medicine on NEJM Knowledge+

Like all NEJM Knowledge+ products, the Learning Lab
courses go through a rigorous internal and external
review process followed by a beta testing evaluation.
Over 120 laboratory medicine professionals have participated in reviewing and performing the beta testingevaluation of these courses.
Learning Lab has been designed for laboratory medicine professionals in hospital laboratories, commercial
laboratories and the in vitro diagnostics industry tohelp them to:
1. Remain abreast with current knowledge
in the field;
2. Maintain certification by obtaining
the required credits;
3. Assess competency, on personalor institutional level; and4. Prepare for certification exams.

Although the primary audience for this programme ismeant to be made up of laboratory medicine professionals at all levels, a secondary audience includes clinicians and other health professionals.
Since courses are built in cellular blocks, specific courses targeting a particular group such as clinical laboratory scientists or certain medical specialty can be easily
constructed.
This programme is available commercially, but priced
reasonably in order to enable those with limited resources to access it. The hope that in the future, institutions and companies will realize the value of thisprogram to their trainees and employees and make itavailable to them.
This article is based on an editorial published in Clinical Chemistry by N. Rifai. (clinchem.2018.296798,
Published October 2018)

7

ADVERTISE
in IFCC eNews!
Showcase your products and initiatives to morethan 15000 laboratory medicine specialists
throughout Europe, Asia-Pacific, Middle
East, Africa and Latin America: laboratory
directors, clinical chemists, and other clinicallaboratory specialists and technologists, leading
manufacturers, distributors and dealers in thefield.
• Ten issues per year
• Free-of-charge to readers• Interactive digital edition

Published ten times a year:
No 1/2		
FebruaryoMarch
N 3 		oN 4 		ApriloMay
N 5 		oN 6 		Juneo
N 7/8 		July
oN 9 		
September
No 10 		October
No 11 		Novembero
N 12 		December

For prices and formats andany further information on
how your company can gain
unique access to international
markets through advertisingwith us, please email us at:enews@ifcc.org.

IFCC Corporate Members receive
a 25% discount on current prices
www.ifcc.org

VLP Report:
Philippine Council for Quality Assurance in Clinical Laboratories (PCQACL)
Manila, Philippines
September 24-28, 2018
by Khosrow Adeli
Chair, IFCC CPDHead and Professor, Clinical Biochemistry, Paediatric Laboratory Medicine
Senior Scientist, Molecular Medicine, Research Institute
The Hospital for Sick Children/University of Toronto - Canada

PCQACL officers with Dr. Godwin Hernaez, Dr. Elizabeth Arcellana Nuqui, and Prof. Khosrow Adeli at the opening ceremony

The Philippine Council for Quality Assurance in ClinicalLaboratories (PCQACL) kindly invited me to be their keynote speaker at their 15th annual conference in September 2018. PCQACL is a non-governmental and non-profit
organization composed of health professionals’ associations, clinical laboratories, both hospital based andfree-standing, and industry partners. PCQACL’s vision is
to be the leader in promoting Quality Services provided by Clinical Laboratories in the Philippines by meansof Advocacy, Training, Education, and Research. PCQACL through its Committee on Continuing Education

and Research conducts annual conventions, symposia,
seminars, round table conferences and workshops toequip and enhance the capabilities and competencies
of Pathologist, Medical Technologists, and other healthprofessionals.
This year the PCQACL held its 2018 annual convention
under the theme of “Sustaining Global Quality Innovations” over three days in Quezon City, Manila. Thisis the premiere conference on Quality for Clinical Laboratories in the Philippines. The event was extremely
well attended with over 1000 participants all of whom
Article continued on next page9

were in attendance throughout the three days of theconference. Participants were medical laboratory professionals including lab scientists/physicians, lab technologist, university faculty, as well as graduate/undergraduate students. There were several presentations
including a plenary presentation by another invited
speaker, Dr. Raja Elina Raja Aziddin, President of Malaysian Association of Clinical Biochemists (MACB).
As an invited speaker, I gave the Keynote presentationand three plenary/interactive talks (30-45 min each).
My Keynote presentation was entitled: Advancing Laboratory Medicine through Innovation: Predicting the
Lab of the Future! I reviewed innovation in all areasof Lab Medicine & Clinical Laboratory Service as well
as exciting new developments In Vitro diagnostics, focusing on nanotechnology, microtechnology (lab ona chip), machine learning, artificial intelligence, automation and robotics, smartphone based diagnostics,
and medical diagnostics data management.
My first plenary presentation was entitled: Lipid Guide­lines in Cardiovascular Risk Stratification. I reviewed

basics of lipid and lipoprotein metabolism and thecurrent guidelines on lipid testing and interpretation. I
also reviewed the recommendations made by various
international guidelines including the Canadian Cardiovascular Society Guidelines for the Management of
Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult.
My second plenary presentation was on Interpreting
Abnormal Routine Lab Results in Cancer Patients.
I conducted an interactive session, together with another speaker, on the challenges faced by the laboratory in interpreting laboratory test results in patientsdiagnosed with cancer. Abnormal biochemical test
results in cancer patients can be either factual or factitious. In other words, they might be real high or low
results, but they also sometimes represent false elevations or decreases. Thus, abnormal results need to
be interpreted with caution and with a thorough understanding of cancer biology, since misinterpretation
could lead to inappropriate medical intervention andnegative consequences for patients.

Organizing Committee members, PCQACL and EB Officers
with Dr. Godwin Hernaez, Dr. Elizabeth Arcellana Nuqui, and Prof. Khosrow Adeli
Article continued on next page10

My third plenary presentation was on Challenges to
Lipid Testing: Introduction of the Non-Fasting Lipid
Profile. I participated in a second interactive session, together with another speaker, on fasting versus
non-fasting lipid testing for cardiovascular risk stratification. I reviewed the advantages of non-fasting lipid
measurements including: non-fasting lipids are more
representative of the normal state, increase convenience for patients, improve patient compliance, eliminates testing difficulty for patients who have trouble
with prolonged fasting (such as children and elderly), and samples can be collected and received in lab
throughout the day.

Despite a very busy presentation schedule, I really enjoyed my time in Manila, closely interacting with ourFilipino colleagues who were extremely warm andkind hosts, very hospitable and friendly.
I want to personally thank all of the organizers particularly the conference president Dr. Godwin Hernaez as
well as other PCQACL board members including Dr.
Elizabeth Arcellana Nuqui, Dr. Pauo Belen, and Ms. Erlinda Cua.
Finally, my sincere thanks to IFCC VLP program for theirsponsorship of my travel as well as Abbott Diagnostics
for funding the VLP program.

NEWS FROM REGIONAL FEDERATIONS AND MEMBER SOCIETIESNews from the Vietnamese Associationof Clinical Biochemists (VACB)
2018 National Scientific Conference of VACB
by Hoang Van Son
National Representative of the VACB to IFCC
The Vietnamese Association of Clinical Biochemists (VACB) received the IFCC-Abbott Visiting Lectureship for the2018 National Scientific Conference in the framework of the Jubilee Ceremony of the 55th Anniversary of the Foundation of the VACB, organized in Da Nang, Vietnam,
between 17-18 August 2018.
The visiting lecturer was Prof. Abderrazek Hedhili,
IFCC EB member. Two lectures of Prof. Abderrazek
Hedhili were highly appreciated by the audience.
A total of 520 members of the VACB attended, frommany provinces of Vietnam, including Hanoi, Ho Chi
Minh-City, Da Nang, Hue, Hai Phong.
The lectures were:

Prof. Abderrazek Hedhili, (TU), IFCC EB member,during the ConferenceÂÂ”Mycotoxins and human health”, andÂÂ“Role of Laboratory in the diagnosisof pesticides intoxications”.

The audience found that these lectures were very
useful, improving their knowledge especially inthe area of toxicology.
Article continued on next page11

These lectures and that of Dr. Raja Elina Raja Aziddin,
APFCB traveling lecturer, President of the Malaysian
Association of Clinical Biochemists: “Methodologies
and Technologies for Therapeutic Drug Monitoringand Drugs of abuse testing” given in this VACB National Scientific Conference greatly contributed to
the VACB Programme of development of Therapeutic Drug Monitoring and Toxicology in the Vietnamese Clinical Laboratories.
The VACB National Committee and the VACB members in the Conference found the great friendship of

the two colleagues from IFCC and APFCB, from Tunisia
and Malaysia very heartwarming.
We express our sincere thanks to you.
On behalf of the Vietnamese Association of Clinical
Biochemists, I would like to express our gratitude andthanks to IFCC and APFCB, to Abbott Diagnostics fortheir generous support, to Prof. Nader Rifai, IFCC-Abbott VLP Chair and the IFCC EMD for generous help in
implementing the VLP in Vietnam.
VACB National Committee

News from the Japanese Society of Clinical Chemistry(JSCC)The JSCC 2018 Article Award
by Hideo Sakamoto
International Exchange Committee of JSCC
The Japan Society of Clinical Chemistry (JSCC) has been the leading society in the field of Clinical Chemistry in Japanfor more than fifty years.
The JSCC Article Award is given annually to a person or persons having made outstanding academic research in thefield of clinical chemistry.
In 2018, Yutaka Suehiro, MD, PhD and Eriko Mori, MS are the winners of the 2018 Article Award.
The award presentation was held at the 58th Annual Meeting of JSCC in
Nagoya, Japan, from 24-26 August, 2018. At the presentation, the award
recipient was congratulated by Dr. Masato Maekawa, President of JSCC,
for their outstanding academic research in clinical chemistry.
In this issue, we would like to introduce two winners work to distribute
their outstanding work.
Yutaka Suehiro, MD, PhD (Department of Oncology & Laboratory Medicine, Yamaguchi University Graduate School of Medicine) is the winnerof the 2018 Article Award, entitled “Highly sensitive stool DNA testingof Fusobacterium Nucleatum as a marker for detection of colorectal
tumours in a Japanese population”.
Accumulating evidence shows an overabundance of Fusobacterium nucleatum (Fn) in colorectal tumor tissues. Although stool DNA testing ofFn might be a potential marker for the detection of colorectal tumors,
the difficulty in detecting Fn in stool by conventional methods prevented further explorations.

Mr. Yutaka Suehiro, winnerof the 2018 JSCC Article Award
Article continued on next page

12

Therefore, they developed a droplet digital PCR assay for detecting Fn in stool and investigated its clinical utility
in the management of colorectal tumors in a Japanese population.
Faeces were collected from 60 healthy subjects (the control group) and from 11 patients with colorectal non-advanced adenomas (the non-advanced adenoma group), 19 patients with colorectal advanced adenoma/carcinoma in situ (the advanced adenoma/CIS group), and 158 patients with colorectal cancer (CRC) of stages I to IV(CRC group).
Absolute copy numbers of Fn were measured by droplet digital PCR. The median copy number of Fn was 17.5 in thecontrol group, 311 in the non-advanced adenoma group, 122 in the advanced adenoma/CIS group, and 317 in the
CRC group. In comparison with that in the control group, the Fn level was significantly higher in the non-advanced
adenoma group, the advanced adenoma/CIS group, and the CRC group.
This study illustrates the potential of stool DNA testing of Fn by droplet digital PCR to detect individuals with colorectal tumors in a Japanese population.
Eriko Mori, MS (Department of Clinical Laboratory, The University of Tokyo Hospital) is the winner of the 2018 Article
Award, entitled “Existence of a squamous cell carcinoma
antigen-immunoglobulin complex causes a deviation between squamous cell carcinoma antigen concentrations determined using two different immunoassays: first report of
SCCA coupling with immunoglobulin A”.
Squamous cell carcinoma antigen (SCCA) is used as a tumor
marker for squamous cell carcinoma and is routinely measured, using an immunoassay in clinical laboratories.
Measurements based on an immunoassay, however, haveseveral issues to be solved. One of them is interference withserum proteins and antibodies, such as heterophilic antibodies, which could make the data falsely high or low. Anotherproblem is the difference in the reactivity to antigen amongcommercially available kits, since each immunoassay uses
different specific antibodies.

Ms. Eriko Mori,
winner of the 2018 JSCC Article Award

Ms. Mori and her co-author have experienced three cases
in which the SCCA concentrations differed considerably between two different SCCA kits, a chemiluminescent immunoassay (CLIA method) and a fluorescent enzyme immunoassay(FEIA method).

Moreover, the SCCA concentrations determined with the CLIA method in these cases maintained at unexplainably high levels after successful treatment. Therefore, they aimed to elucidate the mechanism for the deviationsin the SCCA concentrations in these three cases.
Ms. Mori and her co-author demonstrated that large molecular weight SCCA complexed with IgG (two cases) and
IgG plus IgA (one case) existed in the serum samples collected from these three deviated cases. To our knowledge,
this is the first report which demonstrates the coupling of SCCA with IgA.
In conclusion, the mechanism for the deviation observed between the two immunoassays might be the differencein the reactivity to immune complexes of SCCA with its autoantibody.

13

IFCC's Calendar of Congresses, Conferences & Events
Calendar of IFCC Congresses/Conferences
and Regional Federations' Congresses

May 19 - 23, 2019

XXIII IFCC - EFLM EuroMedLab
Barcelona 2019

Barcelona, ES

Sep 11 - 13, 2019

COLABIOCLI Regional Congress 2019Panama, PA

Nov 17 - 20, 2019

APFCB Regional Congress 2019

Jaipur, IN

May 24 - 28, 2020

XXIV IFCC WorldLab
Seoul 2020

Seoul, KR

May 16 - 20, 2021

XXIV IFCC - EFLM EuroMedLab
Munich 2021

Munich, DE

May 21 - 25, 2023

XXV IFCC - EFLM WorldLab
EuroMedLab - Rome 2023

Rome, IT

Calendar continued on next page14

Calendar of events with IFCC auspices
Nov 1 - 3, 2018

LMCE 2018 and KSLM 59th Annual Meeting

Seoul, KR

Nov 1 - 4, 2018

2nd International Cell Death Research Congress

Izmir, TR

Nov 9 - 12, 2018

18º Congreso Internacional del Colegio Nacionalde Bacteriología

Barranquilla, CO

Nov 13, 2018

Workshop on Alzheimer's disease "Making the point"

Prague, CZ

Nov 14 - 16, 2018

Promoting Research in the area of Vitamin D

Karachi, PK

Nov 15 - 18, 2018

26th AMBICON Annual Conference

New Delhi, IN

Nov 21, 2018

Réunion LABAC

Paris, FR

Nov 26 - 27, 2018

QLAC 2018 - POCT innovation, Connected Health and Beyond:
How digital technology is transforming lab medicine healthand social care?

Nov 28 - Dec 1, 2018

II International Conference of the Bolivian Societyof Clinical Biochemistry

La Paz, BO

Nov 29, 2018

Place and role of the medical biology and lab medicine
in the Health System Transformation Strategy

Paris, FR

Nov 29, 2018

International Scientific Meeting of the Centre of MetrologicalTraceability in Laboratory Medicine (CIRME):"Standardization in Laboratory Medicine and Patient Safety"

Milan, IT

Belgrade, SRB

IV International Conference on Continuous Training
in Clinical Biochemistry and Hematology

Machala, EC

Dec 5 - 6, 2018

4th Annual Meeting, Saudi Society for Clinical Chemistry

Riyadh, SA

Dec 7 - 8, 2018

JBP 2018 - Journées de Biologie Praticienne

Paris, FR

Dec 24 - 27, 2018

ICB 2018 - 2nd International Congress on Biomedicine

Teheran, IR

Feb 7 - 8, 2019

International Congress on Quality in Laboratory Medicine

Helsinki, FI

Mar 22 - 23, 2019

5th EFLM European Conference on Preanalytical Phase“Preanalytical Challenges - time for solutions”

Zagreb, HR

Apr 4 - 5, 2019

10th European Symposium on Clinical Laboratory
and In Vitro Diagnostic Industry: ‘The Clinical Laboratory
in the Pregnancy Monitoring'

Barcelona, ES

Nov 29 - Dec 1, 2018

Calendar continued on next page

15

Apr 11 - 12, 201915th Belgrade Symposium for Balkan Region

Belgrade, SRB

May 18, 2019

VII International Symposium Laboratory Medicine and Quality- Satellite Meeting IFCC-EFLM EUROMEDLAB 2019

Barcelona, ES

May 19, 2019

International Symposium : Breast Cancer and Environment- Satellite Meeting IFCC-EFLM EUROMEDLAB 2019

Barcelona, ES

May 19, 2019

International Symposium: Standardization and Recommendationsin the Laboratory of Haematology - Satellite Meeting IFCC-EFLM
EUROMEDLAB 2019

Barcelona, ES

Jun 29, 2019

The 23rd International Conference on Laboratory Maedicine andPathobiology: An expert forum in clinical and laboratory sciences

Chios Island, GR

Sep 11 - 13, 2019

XXIV Congreso Latinoamericano de Bioquímica Clínica
(COLABIOCLI) and XIV Congreso Nacional de Laboratoristas
Clínicos de Panamá

Panama City, PA

Jun 9 - 12, 2020

XXXVII Nordic Congress in Medical Biochemistry

Trondheim, NO

WORKSHOP
ALZHEIMER’S DISEASE“MAKING THE POINT”
PRAGUECharles University – Carolinum
November 13th, 201816

IFCC MEMBERSHIP
Full Members
Albania (AL)
Algeria (DZ)
Argentina (AR)Australia and New
Zealand (AU/NZ)
Austria (AT)
Belarus (BY)
Belgium (BE)Bolivia (BO)
Bosnia Herzegovina (BA)
Brazil (BR)
Bulgaria (BG)
Canada (CA)Chile (CL)
China (Beijing) (CN)China (Taipei) (TW)
Colombia (CO)Croatia (HR)Cuba (CU)
Cyprus (CY)
Czech Republic (CZ)
Denmark (DK)
Dominican Republic (DO)
Ecuador (EC)Egypt (EG)Estonia (EE)
Ethiopia (ET)Finland (FI)France (FR)Germany (DE)Greece (GR)
Guatemala (GT)Hong Kong (HK)
Hungary (HU)
Iceland (IS)India (IN)Indonesia (ID)
Iran (IR)
Ireland (IE)
Israel (IL)
Italy (IT)Japan (JP)Jordan (JO)
Kazakhstan (KZ)
Kenya (KE)
Korea (KR)Kosovo (XK)

Latvia (LV)
Lebanon (LB)
Lithuania (LT)
Luxembourg (LU)
Macedonia (MK)Malawi (MW)Malaysia (MY)Mexico (MX)Montenegro (MNE)
Morocco (MA)
Netherlands (NL)
Nepal (NP)
Nigeria (NG)
Norway (NO)Pakistan (PK)Palestine (PS)Panama (PA)Paraguay (PY)
Peru (PE)Philippine (PH)Poland (PL)Portugal (PT)
Romania (RO)Russia (RU)
Saudi Arabia (SA)Serbia (SRB)
Singapore (SG)Slovak Republic (SK)Slovenia (SI)South Africa (ZA)
Spain (ES)Sri Lanka (LK)
Sudan (SD)
Sweden (SE)Switzerland (CH)
Syrian Arab Republic (SY)
Thailand (TH)Tunisia (TN)Turkey (TR)Ukraine (UA)United Kingdom (UK)
United States (US)Uruguay (UY)
Vietnam (VN)
Zambia (ZM)
Zimbabwe (ZW)

Regional Federations
Arab Federation of Clinical Biology (AFCB)
African Federation of Clinical Chemistry (AFCC)
Asia-Pacific Federation for Clinical Biochemistry andLaboratory Medicine (APFCB)
European Federation of Clinical Chemistry andLaboratory Medicine (EFLM)
Latin America Confederation of Clinical Biochemistry(COLABIOCLI)North American Federation of Clinical Chemistry andLaboratory Medicine (NAFCC)

Corporate Members
AbbottADx Neurosciences
Agappe Diagnostics, Ltd.
Analis R&D Diag.
Asahi Kasei Pharma Corp., AS
BD Life Sciences – Preanalytical Systems
Beckman Coulter, Inc.
Beijing Dream Diagnostics Medicine (DDM)
Technology Co. Ltd.
The Binding Site Group, Ltd.
Bio-Rad Laboratories
C.P.M. Diagnostic Research, SAS
DiaSys Diagnostic Systems GmbH
DiatronFujifilm Wako Pure Chemical Corporation
Fujirebio Europe
Gentian, AS
Helena Biosciencies Europe
Hemas Hospitals (PVT) Ltd.
HyTest, Ltd.
A. Menarini Diagnostics
Mindray

Mitsubishi Chemical Europe, GmbH
Ningbo MedicalSystem Biotech. Co., Ltd.
Nova Biomedical Corporation
Oneworld Accuracy Collaboration
Ortho-Clinical Diagnostics, Inc.
PPD Inc.
Radiometer Medical ApS
Randox Laboratories, Ltd.
Roche Diagnostics, GmbH
Sebia S.A.
Sekisui Diagnostics (Uk) Ltd.
Sentinel CH SpA
Shanghai Kehua Bio-Engineering Co., Ltd.
Shanghai Zhicheng Biol. Tech. Co., Ltd.
Sichuan Maccura Biotechnology Co., Ltd.
Siemens Healthcare Diagnostics
Snibe Co., Ltd.
Sysmex Europe, GmbH
Thermo Fisher Scientific
Timedico A/SLabor Dr. Wisplinghoff

Affiliate Members
Brazil: Sociedade Brasileira de Patologia Clínica / Medicina Laboratorial (SBPC/ML)
China: Lab Medicine Committee, China Association of Medical Equipment (LMC)
Egypt: Egyptian Association of Healthcare Quality and Patient Safety
France: French National Network of Accredited Laboratories of Medical Biology (LABAC)
India: Association of Medical Biochemists of India (AMBI)
Iran: Iranian Association of Clinical Laboratory Doctors (IACLD)
Jordan: Society for Medical Technology & Laboratories (SMTL)
Kazakhstan: Public Association - Federation of Laboratory Medicine (FLM)
Mexico: Federación Nacional de Químicos Clínicos (CONAQUIC A.C.)
Nepal: Nepalese Association for Clinical Chemistry (NACC)
Philippines: Philippine Council for Quality Assurance in Clinical Laboratories (PCQACL)
Russia: Regional Association for Clinical Laboratory Diagnosis, St. Petersburg
Spain: Asociación Española de Farmacéuticos Analistas (AEFA)
Turkey: Society of Clinical Biochemistry Specialists (KBUD)
Ukraine: Association for Quality Assurance of Laboratory Medicine (AQALM)

Publisher
Communications and Publications
Division (CPD) of the IFCC
Starting in 2018, the Communications
and Publications Division publishes
ten editions of the e-News per year,
including two double issues.

EditorTahir Pillay, MB ChB, PhD, FRCPath (Lon), FCPath (SA)
Department of Chemical Pathology
University of Pretoria, South Africa
E-mail: enews@ifcc.org

Design & Production:www.insoftdigital.com

Circulation
The eNews is distributed to all IFCC members
registered on-line to receive it and to all IFCC
sponsors.

Deadlines for submissions
to the eNews
N° 1/2 – February: by mid January
N° 3 – March: by mid February
N° 4 – April: by mid March
N° 5 – May: by mid April
N° 6 – June: by mid May
N° 7/8 – July/August: by mid June
N° 9 – September: by mid August
N° 10 – October: by mid September
N° 11 – November: by mid October
N° 12 – December: by mid November
If you want to submit an article or advertisement
to be published in the eNews, send it to:
Tahir Pillay, Editor, IFCC eNews
E-mail: enews@ifcc.org

Copyright © 2018 IFCC. All rights reserved.
Contents may not be reproduced without the priorpermission of the Communications and Publications
Division (CPD) of the IFCC.